Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is BrightSpring Health Services, Inc. (BTSG) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question. BrightSpring Health Services, Inc. is one of 1001 companies in the Medical group. The Medical group currently sits at #5 within the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. BrightSpring Health Services, Inc. is currently sporting a Zacks Rank of #1 (Strong Buy). The Zacks Consensus Estimate for BTSG's full-year earnings has moved 0.2% higher within the past quarter. This shows that analyst sentiment has improved and the company's earnings outlook is stronger. According to our latest data, BTSG has moved about 28.2% on a year-to-date basis. At the same time, Medical stocks have lost an average of 5.5%. As we can see, BrightSpring Health Services, Inc. is performing better than its sector in the calendar year. Another Medical stock, which has outperformed the sector so far this year, is Cencora (COR). The stock has returned 29.4% year-to-date. For Cencora, the consensus EPS estimate for the current year has increased 0.4% over the past three months. The stock currently has a Zacks Rank #2 (Buy). Breaking things down more, BrightSpring Health Services, Inc. is a member of the Medical Services industry, which includes 58 individual companies and currently sits at #66 in the Zacks Industry Rank. On average, this group has lost an average of 3% so far this year, meaning that BTSG is performing better in terms of year-to-date returns. Cencora is also part of the same industry. BrightSpring Health Services, Inc. and Cencora could continue their solid performance, so investors interested in Medical stocks should continue to pay close attention to these stocks. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report BrightSpring Health Services, Inc. (BTSG):Free Stock Analysis Report Cencora, Inc. (COR):Free Stock Analysis Report Story Continues This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Has BrightSpring Health Services, Inc. (BTSG) Outpaced Other Medical Stocks This Year?
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...